Syneos Health Announces Pricing of Secondary Offering of Common Stock yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Highlights
GAAP revenue of $1,140.0 million for the three months ended December 31, 2020, representing a sequential increase of 3.7% compared to the three months ended September 30, 2020.
Net new business awards of $1,764.1 million and $5,863.1 million for the three and twelve months ended December 31, 2020, representing book-to-bill ratios of 1.55x and 1.33x, respectively.
Clinical Solutions segment net new business awards of $1,299.3 million and $4,698.7 million for the three and twelve months ended December 31, 2020, representing book-to-bill ratios of 1.52x and 1.42x, respectively, and year-over-year backlog growth of 24.6% as of December 31, 2020.
Commercial Solutions segment net new business awards of $464.8 million and $1,164.4 million for the three and twelve months ended December 31, 2020, representing book-to-bill ratios of 1.63x and 1.05x, respectively.
The Future: How We Can Reach the “Brave New World” of Diverse and Equitable Clinical Trials, Upcoming Webinar Hosted by Xtalks
Share Article
This is the fourth webinar in a four-part series from Syneos Health® titled “Blazing a Trail to Clinical Trial Diversity”. In this free webinar, attendees will learn about potential regulatory changes that could be made to increase greater patient diversity in clinical trials and understand the benefits of inclusive trials. The featured speakers will also discuss how to reward organizations for creating truly equitable clinical trials.
The presenters explore how or if policy innovations, such as regulatory mandates and incentives, can move the industry forward as one.
Syneos Health Schedules Fourth Quarter and Full Year 2020 Earnings Call for Thursday, February 18, 2021
January 26, 2021 18:37 ET | Source: Syneos Health, Inc. Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 26, 2021 (GLOBE NEWSWIRE) Syneos Health
® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2020 financial results on Thursday, February 18, 2021, prior to its earnings call at 8:00 a.m. ET.
Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
When It All Works: Case Studies for Success With Patient Diversity in Clinical Trials, Upcoming Webinar Hosted by Xtalks
Share Article
This is the third webinar in a four-part series from Syneos Health® titled “Blazing a Trail to Clinical Trial Diversity”. In this free webinar, the featured speakers will explore how more diverse clinical trials have been achieved when intentional design and operational changes are enacted. Hear how ethical-scientific commitment, stakeholder engagement and training, and analysis of disease demographics and health system performance can be combined to design and execute equitable trials. Attendees will learn from real case studies how to move forward for broader adoption of more inclusive standards to ensure diverse representation in clinical trial study populations.